LEARNING OBJECTIVES 1. Review the current treatment landscape for MDS and myeloproliferative neoplasms 2. Understand the rationale for novel combination strategies 3. Discuss ongoing investigator-initiated trial and correlative translational studies

Session date: 
12/08/2022 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Gregory Roloff, MD